Tag: Heart Failure

MethHF linked to significant morbidity, including worse heart failure symptoms compared with non-methamphetamine-related heart failure

Less pneumonia, fewer cardiovascular events, deaths, hospitalizations seen during peak flu season

Primary end point similarly reduced for men and women with dapagliflozin; no differences in secondary outcomes, safety events

Less utilization of VAD, transplant seen among Black patients who have heart failure with high-risk features, with no increase in mortality

Lower county food insecurity percentage, higher county food environment index linked to lower heart failure mortality rate

Risks for all-cause death, cardiovascular death, first heart failure hospitalization reduced with higher intake of alpha-linolenic acid

Additional benefits seen for patients with heart failure include higher rates of clinician home visits, more days spent at home

Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction

Risk reduced for primary outcome of worsening heart failure or cardiovascular death

Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure